Here is why Oragenics Inc. (OGEN) stock volatility recorded over the last month was 10.54%

Let’s start up with the current stock price of Oragenics Inc. (OGEN), which is $0.72 to be very precise. The Stock rose vividly during the last session to $0.76 after opening rate of $0.75 while the lowest price it went was recorded $0.68 before closing at $0.76.

Recently in News on August 20, 2020, Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine. Avid Well Positioned to Meet Significant Scale-Up Requirements for NIH-Licensed SARS-CoV-2 Spike Protein Vaccine Candidate . You can read further details here

Oragenics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.0900 on 07/22/20, with the lowest value was $0.3600 for the same time period, recorded on 04/16/20.

Oragenics Inc. (OGEN) full year performance was 77.06%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Oragenics Inc. shares are logging -65.69% during the 52-week period from high price, and 99.19% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.36 and $2.09.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1992727 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Oragenics Inc. (OGEN) recorded performance in the market was 37.11%, having the revenues showcasing 26.94% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 43.92M, as it employees total of 7 workers.

Market experts do have their say about Oragenics Inc. (OGEN)

During the last month, 1 analysts gave the Oragenics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.7387, with a change in the price was noted +0.1397. In a similar fashion, Oragenics Inc. posted a movement of +24.19% for the period of last 100 days, recording 6,948,284 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OGEN is recording 0.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Oragenics Inc. (OGEN)

Raw Stochastic average of Oragenics Inc. in the period of last 50 days is set at 13.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.29%. In the last 20 days, the company’s Stochastic %K was 8.97% and its Stochastic %D was recorded 10.21%.

Bearing in mind the latest performance of Oragenics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 37.11%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -4.03%, alongside a boost of 77.06% for the period of the last 12 months. The shares increased approximately by -22.05% in the 7-day charts and went up by -35.97% in the period of the last 30 days. Common stock shares were driven by 26.94% during last recorded quarter.